Alzheimer's Disease Unified Diagnostic & Therapeutic Platform

About ExQor Technologies

ExQor Technologies is pioneering a novel, two-pronged platform for Alzheimer's disease that integrates diagnosis and treatment. The platform consists of a diagnostic biologic to visualize damaged brain receptors via MRI and a companion therapeutic biologic designed to deliver regenerative proteins directly to those sites, with preclinical data suggesting reversal of neurological damage. An AI-powered software platform personalizes risk assessment and treatment strategy. The company is advancing its lead programs through IND-enabling studies with a regulatory strategy that prioritizes the diagnostic as an entry point.

Therapeutic Areas

Other Alzheimer's Disease Drugs